Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014–2018
, Matthew Gibson, Neeltje van Doremalen, Stephen Nash, Tanja Holloway, Michael Letko, Jacqueline M. Cardwell, Bilal Al Omari, Ahmad Al-Majali, Ehab Abu-Basha, Punam Mangtani, Vincent J. Munster, and Javier Guitian
Author affiliations: The Royal Veterinary College, Hatfield, UK (P. Holloway, J.M. Cardwell, J. Guitian); Glasgow University, Glasgow, Scotland, UK (M. Gibson); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA (N. van Doremalen, M. Letko, V.J. Munster); London School of Hygiene and Tropical Medicine, London, UK (S. Nash, T. Holloway, P. Mangtani); Jordan University of Science and Technology, Irbid, Jordan (B. Al Omari, A. Al-Majali, E. Abu-Basha)
Figure 5. Middle East respiratory syndrome coronavirus seroprevalence among camel population in southern Jordan, stratified by herd size, February 2014–December 2015 and October 2017–October 2018. A) 2014–2015 study; B) 2017–2018 study. Error bars indicate 95% CIs. Numbers within gray boxes depict seropositive camels and total camels per herd size range.
Page created: June 22, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.